Partners Group Holding is nearing a deal to acquire a minority stake in UK pharmaceutical manufacturing services provider Sterling Pharma Solutions, people with knowledge of the matter said.
The Swiss investment group has emerged as the frontrunner in an auction process for the stake, according to the people. A deal is likely to value Sterling Pharma, which is owned by private equity firm GHO Capital, at about $1.2bn or more, they said.
Deliberations are ongoing and talks could still be delayed or falter, the people said, asking not to be identified discussing confidential information. A representative for Partners Group declined to comment, while a spokesperson for GHO Capital didn’t immediately respond to requests for comment.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Based near Newcastle in northeast England, Sterling Pharma provides active pharmaceutical ingredient development and manufacturing services to the global biopharmaceuticals industry. It runs five facilities across the UK, US and Ireland, employing more than 1,300 people, according to its website.
Investors have been keen to expand in the sector as more big drugmakers outsource such functions. GHO invested in Sterling Pharma in 2019.
Source: BNN Bloomberg
Can’t stop reading? Read more
Blackstone explores launch of dedicated private credit secondaries strategy
Blackstone explores launch of dedicated private credit secondaries strategy Blackstone is...
Blue Owl and Koda Capital unlock US private credit access for Australian investors
Blue Owl and Koda Capital unlock US private credit access for Australian investors Blue Owl...
Orangewood backs major 7 Brew franchisee as brand continues rapid US expansion
Orangewood backs major 7 Brew franchisee as brand continues rapid US expansion Orangewood Partners...